Some questions spontaneously arise: does the persistence/loss of IDH mutation after allogenic stem cell transplantation affect the occurrence risk of brain glioma IDH mutant in AML IDH-mutant patients? This evidence concerns the gene IDH1 and acute myeloid leukemia.